3 of the best ASX 200 blue chip shares to buy now

Brokers have good things to say about these shares.

| More on:
A young well-dressed couple at a luxury resort celebrate successful life choices.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • BHP Group, a leading mining company, is valued for its strong cash flow and resilience, with Morgan Stanley giving it an overweight rating and a $46.50 price target.
  • ResMed, focusing on sleep apnoea treatment, combines healthcare defensiveness with tech-like growth, and Macquarie supports it with an outperform rating and a $48.60 price target.
  • Woolworths, a market leader in Australian supermarkets, offers steady cash flows and reliable dividends, with Ord Minnett assigning a buy rating and a $33.00 price target.

Blue chip shares are the backbone of the ASX 200. They're big, established businesses with reliable earnings and strong market positions.

While they may not always deliver explosive short-term gains, they can provide investors with stability, dividends, and long-term growth.

With that in mind, let's take a look at three ASX 200 blue chip shares that analysts believe are attractively priced right now. They are as follows:

BHP Group Ltd (ASX: BHP)

BHP is more than just a miner — it is a global heavyweight with exposure to commodities that underpin modern economies. Iron ore and copper remain its bread and butter, but future growth drivers like potash position the company for the long term.

One thing that makes BHP stand out is its ability to generate enormous free cash flow during strong commodity cycles and return it to shareholders through dividends and buybacks. While commodity prices are cyclical, BHP's scale, efficiency, and balance sheet strength give it resilience that smaller peers simply can't match. This could make it a great pick if you are searching for blue chip exposure to the mining sector.

Morgan Stanley sees value its shares at current levels and has an overweight rating and $46.50 price target on them.

ResMed Inc. (ASX: RMD)

Another ASX 200 blue chip share that could be a buy is ResMed. Its focus on treating sleep apnoea and other chronic respiratory conditions gives it exposure to a vast and growing market. Especially with millions of sufferers still undiagnosed.

ResMed's technology edge lies in its connected devices and digital health platforms, which make treatment more effective for patients and easier for providers to manage. With strong operating leverage, profits are growing faster than revenues, and its balance sheet strength allows it to keep investing in innovation. Overall, ResMed offers the rare combination of healthcare defensiveness and tech-like growth.

The team at Macquarie is bullish on this blue chip and has an outperform rating and $48.60 price target on its shares.

Woolworths Group Ltd (ASX: WOW)

Woolworths is the market leader in Australian supermarkets, and that scale gives it advantages few rivals can replicate. Its grocery division delivers steady cash flows, while ongoing investment in supply chain efficiency and digital channels strengthens its competitive edge.

And while its performance has been disappointing recently, it appears well-placed to stage a recovery in FY 2026.

In addition, Woolworths' reliable dividends are another attraction, especially for income investors, and are underpinned by one of the most defensive business models on the ASX.

Ord Minnett is positive on the company and recently put a buy rating and $33.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Blue Chip Shares

2 big ASX 200 shares this fund manager rates as buys

These large businesses could be strong contenders for returns.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Blue Chip Shares

3 ASX blue-chip shares I'd buy with $3,000 right now

These big stocks have a strong market position. Here’s why they’re buys…

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

3 high-quality ASX 200 shares now trading at multi-year discounts

These shares could be dirt cheap according to analysts.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Blue Chip Shares

Where to invest $10,000 in ASX shares in December

These shares could be great picks for Aussie investors this month.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

These are the top ASX blue-chip shares I'd buy today

I believe these large stocks still have significant growth potential.

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Blue Chip Shares

3 ASX stocks I'd trust with $10,000 for the next decade

Let's see why these blue chips could be great long term picks for investors.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Blue Chip Shares

These top ASX 200 stocks could rise 25% to 60%

These shares could be cheap at current levels according to analysts.

Read more »

Two brokers analysing stocks.
Blue Chip Shares

Why are QBE shares sinking 6% today?

Let's see how the insurance giant is performing in FY 2025.

Read more »